CN Patent

CN101772342A — 用于制造保护活性物质涂层的口服崩解剂型的组合物

Assigned to Choongwae Pharmaceutical Co Ltd · Expires 2010-07-07 · 16y expired

What this patent protects

本发明涉及用于制造口服崩解剂型的组合物，所述剂型用于保护以预定尺寸形成的活性物质涂层以便掩蔽苦味或令人不快的味道。将预定比例的一种具有比具涂层活性物质更低的硬度的赋形剂和另一种具有比具涂层活性物质更高的硬度和更大的粒径的赋形剂用作保护涂层不受破坏的方式。

USPTO Abstract

本发明涉及用于制造口服崩解剂型的组合物，所述剂型用于保护以预定尺寸形成的活性物质涂层以便掩蔽苦味或令人不快的味道。将预定比例的一种具有比具涂层活性物质更低的硬度的赋形剂和另一种具有比具涂层活性物质更高的硬度和更大的粒径的赋形剂用作保护涂层不受破坏的方式。

Drugs covered by this patent

phentermine-hydrochloride (PHENTERMINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN101772342A
Jurisdiction: CN
Classification: —
Expires: 2010-07-07
Drug substance claim: No
Drug product claim: No
Assignee: Choongwae Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.